To evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of Leuprolide Acetate 45 mg 6-month depot formulation in children with Central precocious puberty.
A 52-week study that compares the efficacy of Relamorelin with that of placebo in participants with diabetic gastroparesis with respect to the core signs and symptoms of diabetic gastroparesis (RLM-MD).
